Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 16.06.2026 RCTR.LN IE000J5PESP7 150,002.00 USD 2,816,868.35 18.779 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 16.06.2026 CHPS.LN IE000KXTLDE2 725,002.00 USD 38,415,200.00 52.986 ...
-
Graham Corporation Appoints Jonathan W. Painter as Chairman of the Board
BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum, and advanced mixing technologies for the defense, space, energy, and process industries, today announced that Jonathan W. Painter has been appointed Chairman of the Board of Directors, effective June 15, 2026. The appointment follows the decision by Daniel J. Thoren to retire and step down from his role as Executive Chairman and a...
-
Neuron23 to Accelerate Expansion of NEULARK Phase 2 Trial with Support from The Michael J. Fox Foundation
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Neuron23® Inc., a clinical-stage biotechnology company on a mission to transform the future of Parkinson’s disease through precision medicine, today announced it has received a $2.5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support expansion of the Company’s ongoing Phase 2 NEULARK clinical trial of NEU-411 into Israel. The funding supports activation of four clinical trial sites across Israel and patient sc...
-
Jabil Posts Third Quarter Results
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Today, Jabil Inc. (NYSE: JBL), reported preliminary, unaudited financial results for its third quarter of fiscal year 2026. Third Quarter of Fiscal Year 2026 Highlights: Net revenue: $8.8 billion U.S. GAAP operating income: $445 million U.S. GAAP diluted earnings per share: $2.59 Core operating income (Non-GAAP): $504 million Core diluted earnings per share (Non-GAAP): $3.16 “Jabil delivered a very strong third quarter, with results ahead of our expectatio...
-
JPAR Founder JP Piccinini Aligns with Real to Help Agents and Brokerage Leaders Scale
MIAMI--(BUSINESS WIRE)--The Real Brokerage Inc. (NASDAQ: REAX), a real estate technology platform focused on innovation and agent culture, today announced that entrepreneur and JPAR Real Estate founder JP Piccinini will be working with Real as a Growth Leader. In this role, he will work closely with Chief Growth Officer Jason Cassity to support agents, teams and brokerage leaders across the Real network. Over the course of his career, Piccinini has served as an agent, brokerage owner, franchise...
-
LTM Launches BlueVerse™ on Databricks to Accelerate AI Monetization
SAN FRANCISCO--(BUSINESS WIRE)--LTM Launches BlueVerse™ on Databricks to Accelerate AI Monetization...
-
Medallia Announces Milestone Agreement with Group Led by Blackstone, Apollo, and FSK to Transition Ownership and Position Company for Next Era of Growth
TYSONS, Va.--(BUSINESS WIRE)--Medallia, the global leader in customer and employee experience, today announced that it has entered into a recapitalization agreement with its lenders that will strengthen its financial foundation for long-term growth. The transaction will significantly reduce Medallia’s outstanding debt and provide $150 million of new capital, positioning the company to accelerate AI-driven innovation and customer-focused product investment. Upon completion of the transaction, Med...
-
Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in First-Line Metastatic Pancreatic Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology announces updated results from RAMP 205 clinical trial in first-line metastatic pancreatic ductal adenocarcinoma...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 16.06.2026 MISL.LN IE000NVDQXE1 3,950,002.00 USD 137,477,515.45 34.804 ...